Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo

Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer

Maurizio Scaltriti, Federico Rojo, Alberto Ocaña et al. · JNCI Journal of the National Cancer Institute · 2007 · 881 citations · Full text

Medicine, Cancer Biology, Oncology +17

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Andrew Berchuck, Ayman H. Kamel, Regina S. Whitaker et al. · PubMed · 1990 · 765 citations

Medicine, Oncology, Pathology +17

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

Minna Tanner, Maija Hollmén, Teemu T. Junttila et al. · Annals of Oncology · 2005 · 664 citations

Medicine, Cancer Biology, Oncology +15

Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

Sridhar K. Rabindran, Carolyn Discafani, Edward Rosfjord et al. · Cancer Research · 2004 · 638 citations · Full text

Medicine, Oncology, Pharmacology +13

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

C Wright, Brian Angus, S Nicholson et al. · PubMed · 1989 · 587 citations

Medicine, Oncology, Pathology +17